Drug Search Results
More Filters [+]

Gepirone

Alternative Names: gepirone, Exxua
Latest Update: 2015-05-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: 5-HT1A Partial Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: University of Pennsylvania
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gepirone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Cocaine-Related Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NIDA-00144-3

P2

Completed

Cocaine-Related Disorders

1991-02-01

Recent News Events

Date

Type

Title